{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T14:55:52Z","timestamp":1772204152942,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.bulcan.2020.03.016","type":"journal-article","created":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T07:52:57Z","timestamp":1592293977000},"page":"S130-S139","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"S","title":["Atelier d\u2019harmonisations 2019\u00a0: indications et organisation d\u2019une microtransplantation de cellules souches h\u00e9matopo\u00ef\u00e9tiques"],"prefix":"10.1016","volume":"107","author":[{"given":"J\u00e9r\u00f4me","family":"Cornillon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Carre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yves","family":"Chalandon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrice","family":"Chevallier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Coman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mhamed","family":"Harif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e9l\u00e8ne","family":"Labuissi\u00e8re-Wallet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Baptiste","family":"Mear","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christophe","family":"Picard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahim","family":"Yakoub-Agha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Micha","family":"Srour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bulcan.2020.03.016_bib0145","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s11899-017-0361-6","article-title":"Clinical studies in hematologic microtransplantation","volume":"12","author":"David","year":"2017","journal-title":"Curr Hematol Malig Rep"},{"issue":"12","key":"10.1016\/j.bulcan.2020.03.016_bib0150","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1056\/NEJMra1406184","article-title":"Acute Myeloid Leukemia","volume":"373","author":"D\u00f6hner","year":"2015","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.bulcan.2020.03.016_bib0155","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1182\/blood-2014-08-551499","article-title":"How I treat the older patient with acute myeloid leukemia","volume":"125","author":"Ossenkoppele","year":"2015","journal-title":"Blood"},{"issue":"13","key":"10.1016\/j.bulcan.2020.03.016_bib0160","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1056\/NEJMoa0901409","article-title":"High-dose daunorubicin in older patients with acute myeloid leukemia","volume":"361","author":"L\u00f6wenberg","year":"2009","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.bulcan.2020.03.016_bib0165","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1200\/JCO.2010.30.1820","article-title":"Therapeutic advances in acute myeloid leukemia","volume":"29","author":"Burnett","year":"2011","journal-title":"J Clin Oncol"},{"issue":"15","key":"10.1016\/j.bulcan.2020.03.016_bib0170","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1200\/JCO.2005.05.694","article-title":"Ablative allogeneic hematopoietic cell transplantation in adults 60\u00a0years of age and older","volume":"23","author":"Wallen","year":"2005","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.bulcan.2020.03.016_bib0175","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/ajh.24270","article-title":"Impact of age on outcomes of allogeneic hematopoietic stem cell transplantation with reduced intensity conditioning in elderly patients with acute myeloid leukemia","volume":"91","author":"Aoki","year":"2016","journal-title":"Am J Hematol"},{"key":"10.1016\/j.bulcan.2020.03.016_bib0180","first-page":"1","article-title":"Acute myeloid leukemia in the older adults","volume":"6","author":"Almeida","year":"2016","journal-title":"Leuk Res Rep"},{"key":"10.1016\/j.bulcan.2020.03.016_bib0185","doi-asserted-by":"crossref","first-page":"106314","DOI":"10.1016\/j.leukres.2020.106314","article-title":"Venetoclax combination therapy in relapsed\/refractory acute myeloid leukemia: a single institution experience","volume":"90","author":"Gaut","year":"2020","journal-title":"Leuk Res"},{"issue":"1","key":"10.1016\/j.bulcan.2020.03.016_bib0190","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1182\/blood-2018-08-868752","article-title":"Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia","volume":"133","author":"DiNardo","year":"2019","journal-title":"Blood"},{"issue":"15","key":"10.1016\/j.bulcan.2020.03.016_bib0195","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1200\/JCO.18.01600","article-title":"Venetoclax combined with low-dose cytarabine for previously untreated patients with acute myeloid leukemia: results from a phase Ib\/II study","volume":"37","author":"Wei","year":"2019","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.bulcan.2020.03.016_bib0200","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1182\/blood-2010-06-288506","article-title":"Infusion of HLA-mismatched peripheral blood stem cells improves the outcome of chemotherapy for acute myeloid leukemia in elderly patients","volume":"117","author":"Guo","year":"2011","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.bulcan.2020.03.016_bib0205","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.bbmt.2017.12.802","article-title":"Ultra-sensitive droplet digital PCR for the assessment of microchimerism in cellular therapies","volume":"24","author":"Kliman","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"issue":"12","key":"10.1016\/j.bulcan.2020.03.016_bib0210","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1002\/cncr.31347","article-title":"How I treat older patients with acute myeloid leukemia","volume":"124","author":"Arellano","year":"2018","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.bulcan.2020.03.016_bib0215","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1182\/blood.V98.5.1312","article-title":"The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065\u00a0patients entered into the United Kingdom Medical Research Council AML11\u00a0trial","volume":"98","author":"Grimwade","year":"2001","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.bulcan.2020.03.016_bib0220","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1200\/JCO.1999.17.11.3569","article-title":"Management of acute myeloid leukemia in elderly patients","volume":"17","author":"Hiddemann","year":"1999","journal-title":"J Clin Oncol"},{"issue":"33","key":"10.1016\/j.bulcan.2020.03.016_bib0225","doi-asserted-by":"crossref","first-page":"4084","DOI":"10.1200\/JCO.2012.42.0281","article-title":"HLA-mismatched stem-cell microtransplantation as postremission therapy for acute myeloid leukemia: long-term follow-up","volume":"30","author":"Guo","year":"2012","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.bulcan.2020.03.016_bib0230","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1001\/jamaoncol.2017.2656","article-title":"HLA-mismatched microtransplant in older patients newly diagnosed with acute myeloid leukemia: results from the microtransplantation interest group","volume":"4","author":"Guo","year":"2018","journal-title":"JAMA Oncol"},{"issue":"4","key":"10.1016\/j.bulcan.2020.03.016_bib0235","doi-asserted-by":"crossref","first-page":"524","DOI":"10.5966\/sctm.2015-0196","article-title":"A study of human leukocyte antigen mismatched cellular therapy (stem cell microtransplantation) in high-risk myelodysplastic syndrome or transformed acute myelogenous leukemia","volume":"5","author":"Hu","year":"2016","journal-title":"Stem Cells Transl Med"},{"issue":"1","key":"10.1016\/j.bulcan.2020.03.016_bib0240","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3109\/10428194.2014.914196","article-title":"Programmed haploidentical hematopoietic stem cell infusion combined with systemic chemotherapy improves the outcomes of patients with refractory or relapsed lymphoma","volume":"56","author":"Zhao","year":"2015","journal-title":"Leuk Lymphoma"},{"issue":"5","key":"10.1016\/j.bulcan.2020.03.016_bib0245","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.bbmt.2017.01.085","article-title":"Decitabine before low-dose cytarabine-based chemotherapy combined with human leukocyte antigen \u2013 mismatched stem cell microtransplantation improved outcomes in elderly patients with newly diagnosed acute myeloid leukemia","volume":"23","author":"Zhu","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"issue":"7","key":"10.1016\/j.bulcan.2020.03.016_bib0250","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1080\/10428194.2017.1390235","article-title":"Consolidation therapy with decitabine and intermediate-dose cytarabine followed by HLA-mismatched peripheral blood stem cells infusion for older patients with acute myeloid leukemia in first remission","volume":"59","author":"Li","year":"2018","journal-title":"Leuk Lymphoma"},{"issue":"23","key":"10.1016\/j.bulcan.2020.03.016_bib0255","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1182\/blood.V126.23.156.156","article-title":"HLA-mismatched microtransplantation vs. HLA-matched nonmyeloablative transplantation for acute myeloid leukemia in intermediate-risk: comparable survival but avoids of Gvhd","volume":"126","author":"Guo","year":"2015","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.bulcan.2020.03.016_bib0260","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1007\/s00277-018-3583-3","article-title":"HLA-mismatched stem cell microtransplantation compared to matched-sibling donor transplantation for intermediate\/high-risk acute myeloid leukemia","volume":"98","author":"Liu","year":"2019","journal-title":"Ann Hematol"},{"issue":"3","key":"10.1016\/j.bulcan.2020.03.016_bib0265","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2174\/1389450116666150304103849","article-title":"Do we need full donor chimerism? How alloreactive cell therapies without substantial engraftment might treat hematologic cancers","volume":"18","author":"Krakow","year":"2017","journal-title":"Curr Drug Targets"},{"issue":"10","key":"10.1016\/j.bulcan.2020.03.016_bib0270","first-page":"555","article-title":"Research on the clinical effect and in vitro study of HLA-mismatched hematopoietic stem cell infusion for acute myeloid leukemia","volume":"20","author":"Zhang","year":"2015","journal-title":"Hematol Amst Neth"},{"issue":"6","key":"10.1016\/j.bulcan.2020.03.016_bib0275","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/MOH.0000000000000470","article-title":"Microtransplantation: clinical applications and mechanisms","volume":"25","author":"Cai","year":"2018","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.bulcan.2020.03.016_bib0280","first-page":"18","article-title":"Unrelated HLA mismatched microtransplantation in a patient with refractory secondary acute myeloid leukemia","volume":"9","author":"Punwani","year":"2018","journal-title":"Leuk Res Rep"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455120302526?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455120302526?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T19:32:37Z","timestamp":1757791957000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455120302526"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":28,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S0007455120302526"],"URL":"https:\/\/doi.org\/10.1016\/j.bulcan.2020.03.016","relation":{},"ISSN":["0007-4551"],"issn-type":[{"value":"0007-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Atelier d\u2019harmonisations 2019\u00a0: indications et organisation d\u2019une microtransplantation de cellules souches h\u00e9matopo\u00ef\u00e9tiques","name":"articletitle","label":"Article Title"},{"value":"Bulletin du Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bulcan.2020.03.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Soci\u00e9t\u00e9 Fran\u00e7aise du Cancer. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}